Oncology

AACR In New Partnership For San Antonio Breast Cancer Symposium+

14th December 2007

margaret foti AACR In New Partnership For San Antonio Breast Cancer Symposium
Margaret Foti

MARGARET FOTI, American Association for Cancer Research, Philadelphia
The San Antonio Breast Cancer Symposium will, in the future, be presented jointly by the Cancer Therapy and Research Center at the University of Texas Health Science Center, Baylor College

Read More+

Early Breast Cancer: Survival Benefit For Adjuvant Docetaxel/Cyclophosphamide+

14th December 2007

stephen jones Early Breast Cancer: Survival Benefit For Adjuvant Docetaxel/Cyclophosphamide
Stephen Jones

STEPHEN JONES, US Oncology Research, Houston
Long term data from an early breast cancer trial involving cyclophosphamide combined with docetaxel or doxorubicin have shown a survival advantage for the taxane. As Stephen Jones of US Oncology Research explained

Read More+

Intraperitoneal Catumaxomab Prolongs Survival in Patients With Malignant Ascites from Ovarian Cancer+

1st October 2007

markus heiss  Intraperitoneal Catumaxomab Prolongs Survival in Patients With Malignant Ascites from Ovarian Cancer
Markus Heiss

REFERENCE: ABSTRACT 5001, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
MARKUS HEISS, Klinikum Cologne, Merheim
For patients with malignant ascites as a result of ovarian cancer, a novel intraperitoneal therapy adding the trifunctional

Read More+

ASCO Audio Journal of Oncology in Advance – July 15th, 2007 – reporting from: ASCO Annual Meeting, Chicago, June 1-5, 2007+

15th July 2007

volker diehl ASCO Audio Journal of Oncology in Advance   July 15th, 2007   reporting from: ASCO Annual Meeting, Chicago, June 1 5, 2007
Volker Diehl
george canellos ASCO Audio Journal of Oncology in Advance   July 15th, 2007   reporting from: ASCO Annual Meeting, Chicago, June 1 5, 2007
George Canellos

Hodgkin’s Disease: 10-Year Results Show Further Benefit From Escalated BEACOPP Therapy

REFERENCE: Abstract 8015, ASCO Annual Meeting Chicago June 1-5, 2007
VOLKER DIEHL, University of Cologne
GEORGE CANELLOS, Dana-Farber Cancer Institute, Boston

Long-term results presented at

Read More+

ASCO Annual Meeting Daily News Podcasts – June 5th, 2007+

5th June 2007

aimery degramont ASCO Annual Meeting Daily News Podcasts   June 5th, 2007
Aimery de Gramont
robert mayer ASCO Annual Meeting Daily News Podcasts   June 5th, 2007
Robert Mayer

MOSAIC Study Six Year Results: Adjuvant Oxaliplatin Adds Survival Advantage for Patients with Stage III Colorectal Cancer

REFERENCE: 4007, ASCO Annual Meeting Chicago June 1-5, 2007
AIMERY DE GRAMONT, St Antoine Hospital, Paris
COMMENT: ROBERT

Read More+

ASCO Annual Meeting Daily News Podcasts – June 4th, 2007+

5th June 2007

josep llovet ASCO Annual Meeting Daily News Podcasts   June 4th, 2007
Josep Llovet
robert mayer ASCO Annual Meeting Daily News Podcasts   June 4th, 2007
Robert Mayer

Sorafenib The ‘New Standard’ for Advanced Liver Cancer

REFERENCE: ABSTRACT 5 (Plenary Session), ASCO Annual Meeting Chicago June 1-5, 2007
JOSEP LLOVET, IDIBAPS Hospital Clinic, Barcelona, and Mount Sinai School of Medicine, New York
COMMENT: ROBERT

Read More+

ASCO Annual Meeting Daily News Podcasts – June 3rd, 2007+

4th June 2007

bernard escudier ASCO Annual Meeting Daily News Podcasts   June 3rd, 2007
Bernard Escudier
dean bajorin ASCO Annual Meeting Daily News Podcasts   June 3rd, 2007
Dean Bajorin

Bevacizumab in Advanced Kidney Cancer: Another Treatment Gives Benefit in First Line

REFERENCE: ABSTRACT 3, ASCO Annual Meeting Chicago June 1-5, 2007
BERNARD ESCUDIER, Gustave Roussy Institute, Villejuif
COMMENT: DEAN BAJORIN, Memorial Sloan-Kettering Cancer Center, New

Read More+

Annual Meeting Daily News Podcasts – June 2nd, 2007+

4th June 2007

ben slotman Annual Meeting Daily News Podcasts   June 2nd, 2007
Ben Slotman
roy herbst Annual Meeting Daily News Podcasts   June 2nd, 2007
Roy Herbst

Prophylactic Cranial Irradiation: Fewer Brain Metastases, Longer Survival for Patients with Small Cell Lung Cancer

REFERENCE: ABSTRACT 4, ASCO Annual Meeting Chicago June 1-5, 2007
BEN SLOTMAN, VU Medical Center, Amsterdam
COMMENT: ROY HERBST, MD Anderson

Read More+

Audio Journal of Oncology in Advance – May 15th, 2007 – reporting from: American Association for Cancer Research, April 14-18, 2007, Los Angeles, CA+

16th May 2007

alberto sobrero Audio Journal of Oncology in Advance   May 15th, 2007   reporting from: American Association for Cancer Research,  April 14 18, 2007,  Los Angeles, CA
Alberto Sobrero

Cetuximab With Irinotecan: Phase III Study Shows Benefit in Patients with Oxaliplatin-Refractory Colorectal Cancer

REFERENCE: ABSTRACT LB-2; AACR 2007, Los Angeles, Plenary Session
ALBERTO SOBRERO, Ospedale San Martino, Genoa
Cetuximab could become a mainstay of treatment for colorectal

Read More+

Audio Journal of Oncology in Advance – April 15th, 2007 – Bisphosphonates Recommended for Lung Cancer Bone Metastases+

15th April 2007

peter harper Audio Journal of Oncology in Advance   April 15th, 2007   Bisphosphonates Recommended for Lung Cancer Bone Metastases

PETER HARPER, Guy’s Hospital, London

REFERENCE: “Management of Tumour and Treatment Related Symptoms” section, Perspectives in Lung Cancer, Seville
Bisphosphonates may be more suited for improving the outlook among patients with lung cancer who have bone metastases compared to palliative …
Read More+

Audio Journal of Oncology in Advance – April 1st, 2007 – reporting From: Journal of Clinical Oncology, January 20th, 2007 & December 20, 2006+

2nd April 2007

george canellos Audio Journal of Oncology in Advance   April 1st, 2007   reporting From: Journal of Clinical Oncology, January 20th, 2007 & December 20, 2006
George Canellos

robert motzer Audio Journal of Oncology in Advance   April 1st, 2007   reporting From: Journal of Clinical Oncology, January 20th, 2007 & December 20, 2006
Robert Motzer

Hormone Replacement Therapy: Better Survival With Colorectal Cancer

REFERENCE: J Clin Oncol 24:5680-5686
GEORGE CANELLOS, Dana-Farber Cancer Institute, Boston
Using postmenopausal estrogen replacement before the diagnosis of colorectal cancer was associated with better cancer-specific and

Read More+

When Good Cells Go Bad: The Stem Cell Origin of Cancers+

16th March 2007

david jablons 120 When Good Cells Go Bad: The Stem Cell Origin of Cancers

DAVID JABLONS, University of California, San Francisco

REFERENCE: Keynote Lecture, Perspectives in Lung Cancer Conference, 2-3 March 2007, Seville, Spain
Cell signalling using the Wnt pathway may hold the key to many, if not all, the genetic pathways to cancer, …
Read More+